95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.59%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.62%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-15.52%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-15.52%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-18.77%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.05%
Slight or no buybacks while NEM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.11%
Slight or no buyback while NEM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-44.76%
Dividend reduction while NEM stands at 0.25%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-6.99%
Negative OCF growth while NEM is at 14.97%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
31.55%
FCF growth 1.25-1.5x NEM's 28.62%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
13.95%
Positive 10Y revenue/share CAGR while NEM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
12.85%
5Y revenue/share CAGR above 1.5x NEM's 7.42%. David Dodd would look for consistent product or market expansions fueling outperformance.
42.63%
3Y revenue/share CAGR above 1.5x NEM's 11.89%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-5.57%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
21.90%
Positive OCF/share growth while NEM is negative. John Neff might see a comparative advantage in operational cash viability.
82.91%
3Y OCF/share CAGR similar to NEM's 79.56%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
-21.60%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
59.10%
5Y net income/share CAGR at 50-75% of NEM's 100.56%. Martin Whitman might see a shortfall in operational efficiency or brand power.
290.73%
3Y net income/share CAGR above 1.5x NEM's 101.38%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
86.13%
10Y equity/share CAGR above 1.5x NEM's 1.31%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
18.37%
5Y equity/share CAGR at 50-75% of NEM's 35.96%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
14.03%
Below 50% of NEM's 42.97%. Michael Burry suspects a serious short-term disadvantage in building book value.
323.53%
10Y dividend/share CAGR above 1.5x NEM's 83.81%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
190.02%
Below 50% of NEM's 1988.68%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
66.46%
Below 50% of NEM's 286.21%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-24.73%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
280.32%
Inventory growth well above NEM's 2.21%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.09%
Positive asset growth while NEM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.97%
Positive BV/share change while NEM is negative. John Neff sees a clear edge over a competitor losing equity.
-7.67%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-36.65%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.